Table 6:
Causes of death during follow-up
| Diagnosis | Frequency | Percent | Elevated ALT at baseline (%) |
|---|---|---|---|
| CHF | 280 | 2.5 | 14.3 |
| Malignancy | 258 | 2.3 | 14 |
| Sepsis | 198 | 1.7 | 11.1 |
| MI | 85 | 0.8 | 20 |
| CVA | 56 | 0.5 | 10.7 |
| COPD | 36 | 0.3 | 13.9 |
| Unknown | 30 | 0.3 | 20 |
| Trauma | 15 | 0.1 | 13.3 |
| PVD | 13 | 0.1 | 15.4 |
| ESKD | 7 | 0.1 | 28.6 |
| PE | 6 | 0.1 | 16.7 |
| ILD | 5 | 0.0 | 20 |
| SBO | 5 | 0.0 | 20 |
| NASH cirrhosis | 3 | 0.0 | 33.3 |
| Pancreatitis | 1 | 0.0 | 0 |
| LBO | 1 | 0.0 | 0 |
| Drug overdose | 1 | 0.0 | 0 |
| Survived at follow-up | 10,324 | 91.2 | 14.5 |
| Total | 11,324 | 100 | - |
Abbreviations: CHF- congestive heart failure, MI- myocardial infarction, CVA- cerebrovascular accident, COPD- chronic obstructive pulmonary disease, PVD- peripheral vascular disease, ESKD- end stage kidney disease, PE- pulmonary embolism, ILD- interstitial lung disease, SBO- small bowl obstruction, NASH- nonalcoholic steatohepatitis, LBO- large bowl obstruction.